Related Experiment Videos
Cyclic AMP in macrophages from experimental granulomas and the effect of prostaglandin E2
Abstract:
Leucocytes were isolated by pronase digestion from granuloma tissue at different stages in inflammation induced by carrageenin-soaked sponge implants in rats and cyclic AMP was measured in these cells. In a mixed cell suspension, containing granulocytes and macrophages, the cyclic AMP levels increased during the early stages of inflammation but decreased when the granuloma became established. However, after correction for the proportion of infiltrating macrophages, as the inflammation progressed only a fall in cyclic AMP content was observable. Exposure of granuloma-derived cells to PGE2 resulted in a rise in cyclic AMP content, which was more pronounced in cells isolated during a later rather than an earlier stage of granuloma development. The results provide support for the earlier proposal that the anti-inflammatory effect of E-type prostaglandins on granulomas is partially explicable on the basis of cyclic AMP changes in infiltrating macrophages.
Insights
Cyclic AMP levels in inflammatory cells initially rise then fall during granuloma development. Prostaglandin E2 (PGE2) increases cyclic AMP, suggesting a role in anti-inflammatory effects.
Area of Science:
- Immunology
- Cell Biology
- Pharmacology
Background:
- Granuloma formation is a key feature of chronic inflammation.
- Cyclic AMP (cAMP) is a crucial second messenger involved in regulating cellular functions, including immune responses.
- Prostaglandins, particularly E-type prostaglandins (PGE2), are known to possess anti-inflammatory properties.
Purpose of the Study:
- To investigate the dynamic changes in cyclic AMP (cAMP) levels within leukocytes during the progression of inflammation-induced granuloma formation.
- To determine the effect of Prostaglandin E2 (PGE2) on cAMP levels in cells isolated from developing granulomas.
- To elucidate the role of cAMP modulation in the anti-inflammatory mechanisms of PGE2 in granuloma models.
Main Methods:
- Isolation of leukocytes (granulocytes and macrophages) from rat granuloma tissue at various inflammatory stages using pronase digestion.
- Measurement of intracellular cyclic AMP (cAMP) levels in mixed cell suspensions and after correcting for macrophage infiltration.
- In vitro exposure of granuloma-derived cells to Prostaglandin E2 (PGE2) to assess its impact on cAMP levels.
Main Results:
- In mixed leukocyte populations, cAMP levels initially increased in early inflammation but decreased as granulomas became established.
- After adjusting for macrophage content, a consistent decrease in cAMP was observed as inflammation progressed.
- Exposure to PGE2 significantly elevated cAMP levels in granuloma cells, with a more pronounced effect in cells from later stages of inflammation.
Conclusions:
- The observed changes in cAMP levels in leukocytes correlate with the progression of granuloma inflammation.
- Prostaglandin E2 (PGE2) effectively increases cAMP in granuloma-associated cells, suggesting a mechanism for its anti-inflammatory action.
- These findings support the hypothesis that cAMP modulation in infiltrating macrophages contributes to the anti-inflammatory effects of E-type prostaglandins on granulomas.